Nu Skin Enterprises, Inc. (NUS) Updates Q3 Earnings Guidance

Parametric Port Associate Limited Liability Co invested in 4,794 shares. The President now owns $3,837,888 of the stock per the Form 4 SEC filing. Smithfield Trust reported 0.01% in Nu Skin Enterprises, Inc. They expect $0.86 earnings per share, down 8.51% or $0.08 from last year's $0.94 per share. Credit Suisse AG raised its position in shares of Nu Skin Enterprises by 64.9% during the first quarter. Corporate insiders own 5.20% of the company's stock.

Investors are feeling more bullish on Nu Skin Enterprises, Inc. of late if you take note of the downtick in short interest. Gwm Advisors LLC owns 6,816 shares with a value of $427,127,000. Jensen Investment Management Inc. raised its position in shares of Nu Skin Enterprises by 24.3% during the second quarter. Cantab Capital Partners Llp claims 11,978 shares worth $753,000,000. Bank of New York Mellon Corp now owns 885,257 shares of the company's stock worth $55,628,000 after acquiring an additional 160,495 shares during the last quarter. Llc has invested 1.12% in the stock.

A number of brokerages recently weighed in on NUS. (NYSE:NUS) to report earnings on November, 2. Two research analysts have rated the stock with a sell rating, three have assigned a hold rating and four have issued a buy rating to the company. Bank of America Corporation boosted their target price on Nu Skin Enterprises from $53.00 to $57.00 and gave the company an underperform rating in a research report on Monday, July 10th. BidaskClub lowered shares of Nu Skin Enterprises from a "strong-buy" rating to a "buy" rating in a report on Monday, July 31st.

(ARCC) Shares Bought by Chicago Partners Investment Group LLC
The institutional investors in our partner's database reported: 170.64 million shares, down from 178.56 million shares in 2017Q1. It improved, as 48 investors sold FB shares while 553 reduced holdings. 74 funds opened positions while 313 raised stakes.

Among 27 analysts covering Boston Scientific Corporation (NYSE:BSX), 21 have Buy rating, 0 Sell and 6 Hold. Stifel Nicolaus upgraded it to "Hold" rating and $17.0 target in Thursday, January 26 report. Cubist Systematic Strategies has 0.04% invested in Nu Skin Enterprises, Inc.

WARNING: This report was originally posted by TrueBlueTribune and is the sole property of of TrueBlueTribune. If you are reading this article on another publication, it was illegally copied and republished in violation of United States & global trademark and copyright law. It dived, as 25 investors sold NUS shares while 83 reduced holdings. (NYSE:NUS) has "Buy" rating given on Thursday, August 3 by Pivotal Research. (NYSE:NUS) has risen 46.60% since October 11, 2016 and is uptrending. The firm has a 50-day moving average price of $61.42 and a 200-day moving average price of $59.19. The company has market cap of $945.45 million.

Nu Skin Enterprises (NYSE:NUS) last posted its quarterly earnings data on Wednesday, August 2nd. After having $0.77 EPS previously, Nu Skin Enterprises, Inc.'s analysts see -2.60% EPS growth. The firm had revenue of $550.10 million during the quarter, compared to analysts' expectations of $548.09 million.

Analyst Buzz: Skechers USA, Inc. (SKX)
The investment managers in our partner's database now possess: 102.18 million shares, up from 95.88 million shares in 2017Q1. Legal And General Group Public Limited Company holds 0% of its portfolio in Skechers USA Inc (NYSE:SKX) for 112,814 shares.

The stock of Nu Skin Enterprises, Inc. The company's quarterly revenue was down 8.4% compared to the same quarter a year ago. During the same quarter in the prior year, the company posted $0.79 EPS. As of the last earnings report the EPS was $2.99 and is expected to be $3.23 for the current year with 52,942,000 shares presently outstanding.

The firm also recently declared a quarterly dividend, which was paid on Wednesday, September 13th. Shareholders of record on Friday, August 25th were given a dividend of $0.36 per share. This represents a $1.44 dividend on an annualized basis and a yield of 2.29%. The ex-dividend date was set for Wednesday the 23rd of August 2017. The stock of Nu Skin Enterprises, Inc.

In other news, President Ryan S. Napierski sold 6,933 shares of the stock in a transaction that occurred on Tuesday, October 10th. The stock was sold at an average price of $62.48, for a total value of $287,845.36. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, President Ryan S. Napierski sold 8,000 shares of the stock in a transaction that occurred on Tuesday, July 25th. The stock was sold at an average price of $65.00, for a total value of $520,000.00. Following the transaction, the director now directly owns 63,753 shares of the company's stock, valued at $3,983,287.44. The disclosure for this sale can be found here. On Friday, May 5 CHASE PETER R sold $104,000 worth of Chase Corporation (NYSEAMERICAN:CCF) or 1,000 shares.

Stocks Views And Recommendations: Parkway, Inc. (PKY), Marathon Petroleum Corporation (MPC)
The rating was downgraded by Barclays Capital on Monday, October 17 to "Equal Weight". "Dropped Today" on October 03, 2017. This is calculated by taking weekly log normal returns and standard deviation of the share price over one year annualized.

Nu Skin Enterprises, Inc is a direct selling company that develops and distributes personal care products and nutritional supplements, and a range of other products and services. The Company offers anti-aging personal care products and nutritional supplements under its Nu Skin and Pharmanex brands. The Nu Skin brand offers a range of products, including ageLOC Me customized skin care system, ageLOC Spa systems and ageLOC Transformation anti-aging skin care system. (NYSE:NUS) on Thursday, September 22 with "Hold" rating.

Latest News